PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2016.024201749144-53Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program CohortMinkyu Jung, Jeeyun Lee, Tae Min Kim, Dae Ho Lee, Jin Hyung Kang, Sung Young Oh, Soo Jung Lee, Sang Joon Shinhttp://e-crt.org/upload/pdf/crt-2016-024.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2016.024, http://www.e-crt.org/upload/pdf/crt-2016-024.pdf
The Journal of Dermatology10.1111/1346-8138.15521202047111267-1275Real‐world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanomaAkira Takahashi, Kenjiro Namikawa, Dai Ogata, Eiji Nakano, Shunichi Jinnai, Kenta Nakama, Keita Tsutsui, Yusuke Muto, Haruki Mizuta, Naoya Yamazakihttps://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15521, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/1346-8138.15521, https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15521
10.21203/rs.3.rs-1331173/v12022Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort studySachin Ahuja, Madeline Brendle, Leo Smart, Claire Moore, Paul Thielking, Reid Robisonhttps://www.researchsquare.com/article/rs-1331173/v1, https://www.researchsquare.com/article/rs-1331173/v1.html
10.21203/rs.3.rs-34633/v12020Real-world effectiveness, treatment pattern, and safety of ranibizumab in Korean patients with neovascular age-related macular degeneration: Subgroup analyses from the LUMINOUS studyMin Sagong, Se Joon Woo, Youkyung Leehttps://www.researchsquare.com/article/rs-34633/v1, https://www.researchsquare.com/article/rs-34633/v1.html
Annals of Oncology10.1016/j.annonc.2020.10.199202031S1308178P Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysisJ. Cheon, C. Yoo, Y. Bang, H. Chon, B-Y. Ryoohttps://api.elsevier.com/content/article/PII:S0923753420426900?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420426900?httpAccept=text/plain
10.21203/rs.3.rs-59508/v12020Real-world Efficacy and Safety of Dulaglutide in Korean Patients with Type 2 Diabetes Mellitus: A Retrospective Study in a Tertiary Referral CenterJee Hee Yoon, A Ram Hong, Wonsuk Choi, Ji Yong Park, Hee Kyung Kim, Ho-Cheol Kanghttps://www.researchsquare.com/article/rs-59508/v1, https://www.researchsquare.com/article/rs-59508/v1.html
Annals of Oncology10.1016/s0923-7534(20)33682-6201223ix367-ix368The European Ipilimumab Expanded Access Programme (EAP): Efficacy and Safety Data from the Italian Cohort of Patients with Pretreated, Advanced MelanomaP.A. Ascierto, V. Chiarion Sileni, M. Del Vecchio, M. Altomonte, F. De Galitiis, L. Ridolfi, F. Cognetti, A. Testori, M.G. Bernengo, P. Queirolohttps://api.elsevier.com/content/article/PII:S0923753420336826?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420336826?httpAccept=text/plain
Korean Journal of Ophthalmology10.3341/kjo.2018.00812019332150Short-term Efficacy and Safety of Ranibizumab for Neovascular Age-related Macular Degeneration in the Real World: A Post-marketing Surveillance StudySe Joon Woo, Ga Eun Cho, Joon Hee Chohttps://synapse.koreamed.org/pdf/10.3341/kjo.2018.0081, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2018.0081, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2018.0081
The Journal of Dermatology10.1111/1346-8138.153882020478834-848Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillanceNaoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara, Tetsuya Tsuchida, Keiko Maruyama, Naoki Shakunaga, Eijun Itakura, Akira Komotohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1346-8138.15388, https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15388, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/1346-8138.15388, https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15388
The Korean Journal of Hepatology10.3350/kjhep.2009.15.2.2272009152227Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinomaJeong Heohttp://synapse.koreamed.org/pdf/10.3350/kjhep.2009.15.2.227, http://synapse.koreamed.org/DOIx.php?id=10.3350/kjhep.2009.15.2.227, http://www.e-cmh.org/upload/pdf/27403738.pdf